搜索
Aquestive Therapeutics Inc
AQST添加自选
3.695USD
-0.025-0.67%
收盘 07-31 16:00（美东）报价延迟15分钟
463.60M总市值
亏损市盈率 TTM
关于 Aquestive Therapeutics Inc 公司
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in developing orally administered and topical gel products to deliver complex molecules, providing novel alternatives to invasive and inconvenient standard of care therapies. It has four commercialized products marketed by the Company’s licensees in the United States and around the world and is the manufacturer of these licensed products. The Company also collaborates with pharmaceutical companies to bring new molecules to market using proprietary technologies, including PharmFilm, and has proven drug development and commercialization capabilities. The Company is advancing a late-stage proprietary product candidate for the treatment of severe allergic reactions, including anaphylaxis, and an early-stage epinephrine prodrug topical gel product candidate for various possible dermatology conditions. Its portfolio includes Anaphylm, AQST-108, Libervant, Suboxone, and Emylif.
Aquestive Therapeutics Inc简介
公司代码AQST
公司名称Aquestive Therapeutics Inc
上市日期Jul 25, 2018
CEOBarber (Daniel R)
员工数量142
证券类型Ordinary Share
年结日Jul 25
公司地址30 Technology Dr
城市WARREN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编07059-5166
电话19089411900
网址https://aquestive.com/
公司代码AQST
上市日期Jul 25, 2018
CEOBarber (Daniel R)
Aquestive Therapeutics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.64M
-1.53%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
517.40K
-40.94%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
282.48K
-7.18%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
281.51K
-20.17%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
238.40K
-1.14%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
200.56K
-36.27%
Dr. Gregory B. Brown, M.D.
Dr. Gregory B. Brown, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
75.08K
--
Mrs. Abigail L. Jenkins
Mrs. Abigail L. Jenkins
Independent Director
Independent Director
19.00K
--
Dr. Melina T. Cioffi, Pharm.D.
Dr. Melina T. Cioffi, Pharm.D.
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
--
--
Mr. John S. Cochran, CPA
Mr. John S. Cochran, CPA
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.64M
-1.53%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
517.40K
-40.94%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
282.48K
-7.18%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
281.51K
-20.17%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
238.40K
-1.14%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
200.56K
-36.27%
常见问题
Aquestive Therapeutics Inc的前五大股东是谁？
Aquestive Therapeutics Inc 的前五大股东如下：Mr. Daniel Barber
有多少机构持有Aquestive Therapeutics Inc(AQST)的股份？
截至2026Q1，共有350家机构持有Aquestive Therapeutics Inc的股份，合计持有的股份价值约为74.94M，占公司总股份的60.30%。与2025Q4相比，机构持股有所增加，增幅为-7481130.00。